跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,252 条关于
“Blackstone Multi-Asset Investing”
全部
26,252
临床试验
20,263
药物
100
机构
76
资讯
5,813
去年
Rezolute Secures $90 Million in Public Offering to Advance Rare Disease Therapies
去年
SAB BIO Secures $175 Million Funding to Advance Type 1 Diabetes Immunotherapy Through Phase 2b Trial
2个月前
Ollin Biosciences Secures $330M Series B to Advance Vabysmo Challenger into Phase 3 Trials
4个月前
Mentari Therapeutics Goes Public Through $421M Reverse Merger to Advance Novel PACAP-Targeting Migraine Therapies
9个月前
Athira Pharma Secures $236 Million Financing and Exclusive Rights to Lasofoxifene for ESR1-Mutant Metastatic Breast Cancer
9个月前
Hoth Therapeutics Advances Multi-Asset Pipeline with Phase 2 Progress and Orphan Drug Designation
去年
Anocca Submits Clinical Trial Application to EMA for ANOC-001 in Advanced Pancreatic Cancer
10个月前
Merck Secures $700 Million from Blackstone to Advance TROP2-Targeting ADC Across 15 Phase 3 Cancer Trials
去年
Axsome Therapeutics Secures $570 Million Credit Facility from Blackstone to Strengthen CNS Portfolio
5个月前
Blackstone Closes Record $6.3 Billion Life Sciences Fund, Largest Private Investment Vehicle in Sector History
第 1 页，共 582 页
上一页
下一页
